Seller record · Telehealth service

GobyMeds

By Peptide Alliance, Editorial publisherRecorded September 2026 · Standard v1.1 · How checks are performed

Fails 2 of 8 criteria. S3, pharmacy identification: The site names no filling pharmacy. Terms, privacy, disclaimers, safety and telemedicine pages refer to the pharmacy and stop there. 1 more criterion also fails; see the table below.

At a glance

GobyMedsTelehealth service

5/8criteria passed

Price: From $99 a month
Sells: compounded semaglutide, sermorelin, weight management programs, and 1 more
FDA letters: None on file

Visit GobyMeds See all eight dispositions

Telehealth service. Passes 5 of 8 criteria. 1 not verified, counting neither way. Recorded against Standard v1.1.

A telehealth service selling compounded semaglutide and sermorelin from a Delaware address. It prints a dose-by-dose price list and puts account registration before any medical question.

Operating entity Goby Health LLC

Dispositions

Code	Criterion	Disposition	Where it appears
S1	Prescriber requirement	PASS	GobyMeds' website
S2	Prescription gating	NOT VERIFIED	GobyMeds' register page on its patient site
S3	Pharmacy identification	FAIL	GobyMeds' terms of service page
S4	Compounding disclosure	PASS	GobyMeds' safety information semaglutide page
S5	Analytical documentation	FAIL	GobyMeds' safety information page
S6	Business address	PASS	GobyMeds' disclaimers page
S7	Price disclosure	PASS	GobyMeds' pricing page
S8	Enforcement status	PASS	FDA warning-letter index

Evidence, criterion by criterion

The evidence behind each disposition in the table above, where it appears, and its date.

S1PASSA licensed provider decides whether treatment is appropriate before anything ships, and no individual prescriber is named.Source: GobyMeds' website.

S2NOT VERIFIEDThe medical intake did not resolve, because the order path reaches account registration, which asks only for an email address and a password. The check is open.Source: GobyMeds' register page on its patient site.

S3FAILThe site names no filling pharmacy. Terms, privacy, disclaimers, safety and telemedicine pages refer to the pharmacy and stop there.Source: GobyMeds' terms of service page.

S4PASSCompounded semaglutide is not FDA approved, and the safety page says so in those words.Source: GobyMeds' safety information semaglutide page.

S5FAILNo certificate, lot number or purity figure appears anywhere on the site.Source: GobyMeds' safety information page.

S6PASSA footer on every page prints a street address with a suite number on The Green in Dover, Delaware.Source: GobyMeds' disclaimers page.

S7PASSPrograms start at 99 dollars a month, and the pricing page prints 299 dollars for the opening dose band.Source: GobyMeds' pricing page.

S8PASSNo FDA warning letter names the entity, and no action has halted the business.Source: FDA warning-letter index.

Products shown on the seller's own pages at the recorded date: compounded semaglutide, sermorelin, weight management programs, anti-aging therapies.

Other sellers of the same products

Who sells semaglutide Who sells sermorelin

Visit GobyMeds

Dispositions recorded against Standard v1.1. Method and null semantics: how checks are performed. This record is not a review and contains no medical advice.